INFLUENCE OF HEPATIC CIRRHOSIS AND END-STAGE RENAL-DISEASE ON PHARMACOKINETICS AND PHARMACODYNAMICS OF FUROSEMIDE

被引:90
作者
KELLER, E
HOPPESEYLER, G
MUMM, R
SCHOLLMEYER, P
机构
关键词
D O I
10.1007/BF00554663
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:27 / 33
页数:7
相关论文
共 24 条
[1]   URINARY SODIUM - POTASSIUM RATIO AND RESPONSE TO DIURETICS IN RESISTANT EDEMA [J].
ALEXANDER, WD ;
BRANCH, RA ;
LEVINE, DF ;
HARTOG, M .
POSTGRADUATE MEDICAL JOURNAL, 1977, 53 (617) :117-121
[2]  
ANDREASEN F, 1974, ACTA PHARMACOL TOX, V35, P49
[3]   DISTRIBUTION, ELIMINATION AND EFFECT OF FUROSEMIDE IN NORMAL SUBJECTS AND IN PATIENTS WITH HEART-FAILURE [J].
ANDREASEN, F ;
MIKKELSEN, E .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 12 (01) :15-22
[4]  
BEERMANN B, 1977, CLIN PHARMACOL THER, V22, P70
[5]   PHARMACOKINETICS-PHARMACODYNAMICS OF FUROSEMIDE IN MAN - REVIEW [J].
BENET, LZ .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1979, 7 (01) :1-27
[6]   DETERMINANTS OF RESPONSE TO FRUSEMIDE IN NORMAL SUBJECTS [J].
BRANCH, RA ;
ROBERTS, CJC ;
HOMEIDA, M ;
LEVINE, D .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 4 (02) :121-127
[7]   FUROSEMIDE IN PATIENTS WITH HEART-FAILURE - SHIFT IN DOSE-RESPONSE CURVES [J].
BRATER, DC ;
CHENNAVASIN, P ;
SEIWELL, R ;
BECK, J .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (02) :182-186
[8]   PHARMACODYNAMIC ANALYSIS OF THE FUROSEMIDE-PROBENECID INTERACTION IN MAN [J].
CHENNAVASIN, P ;
SEIWELL, R ;
BRATER, DC ;
LIANG, WMM .
KIDNEY INTERNATIONAL, 1979, 16 (02) :187-195
[9]   CLINICAL PHARMACOKINETICS OF FRUSEMIDE [J].
CUTLER, RE ;
BLAIR, AD .
CLINICAL PHARMACOKINETICS, 1979, 4 (04) :279-296
[10]  
CUTLER RE, 1974, CLIN PHARMACOL THER, V15, P588